Product
CARE T cells
1 clinical trial
6 indications
Indication
Liver CancerIndication
RhabdomyosarcomaIndication
Malignant Rhabdoid TumorIndication
LiposarcomaIndication
Wilms tumorIndication
yolk sac tumorClinical trial
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressing Autologous T Cells as an Immunotherapy for Children With Solid Tumors (CARE)Status: Not yet recruiting, Estimated PCD: 2026-08-01